{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:38:56Z","timestamp":1794649136741,"version":"4.9.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Perivascular epithelioid cell neoplasms (PEComas) are a family of mesenchymal tumors with features of both smooth muscle and melanocytic differentiation. A subset of PEComas demonstrate rearrangements involving the <jats:italic>TFE3<\/jats:italic> (Xp11) locus. Xp11 translocation PEComa is a rare neoplasm with special clinicopathological features and a more aggressive behavior. We recently encountered a case of Xp11 translocation PEComa occurring in the testis, with <jats:italic>SFPQ<\/jats:italic>\u2043<jats:italic>TFE3<\/jats:italic> rearrangement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 57-year-old male touched a mass in his testis incidentally. MRI revealed a 10\u00a0mm diameter mass in the right testis. The patient underwent radical orchiectomy. Gross examination revealed a well-demarcated mass from the surrounding testicular tissue. Microscopically, the tumor mainly displayed nested or sheet-like architecture separated by delicate fibrovascular septa. The tumor cells exhibited marked nuclear atypia and pleomorphism. Immunohistochemistry showed that the tumor cells were strongly positive for cathepsin-K, HMB45 and TFE3. Molecular analysis revealed <jats:italic>SFPQ<\/jats:italic>\u2043<jats:italic>TFE3<\/jats:italic> gene fusion. Thus, it was diagnosed as primary Xp11 translocation PEComa of the testis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present case reports primary Xp11 translocation PEComa of the testis for the first time, which to our knowledge has not been described in the literature in this anatomic site, where it could potentially be problematic in diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-023-01288-x","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T05:02:49Z","timestamp":1673845369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Primary Xp11 translocation PEComa of the testis with SFPQ\u2043TFE3 rearrangement: a case report and review of the literature"],"prefix":"10.1186","volume":"18","author":[{"given":"Huizhi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"1288_CR1","first-page":"312","volume-title":"WHO classification of Tumours\u00b75th Edition: soft tissue and bone tumours [M]","author":"WHO Classification of Tumours Editorial Board","year":"2020","unstructured":"WHO Classification of Tumours Editorial Board. WHO classification of Tumours\u00b75th Edition: soft tissue and bone tumours [M]. Lyon: IARC Press; 2020. pp. 312\u20134."},{"key":"1288_CR2","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","volume":"34","author":"P Argani","year":"2010","unstructured":"Argani P, Aulmann S, Illei PB, et al. A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol. 2010;34:1395\u2013406.","journal-title":"Am J Surg Pathol"},{"key":"1288_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/PAS.0000000000001592","volume":"45","author":"NM Neumann","year":"2021","unstructured":"Neumann NM, Haffner MC, Argani P, et al. Histopathologic characterization of bladder perivascular epithelioid cell neoplasms (PEComa): a series of 11 cases with a subset having TFE3 rearrangements. Am J Surg Pathol. 2021;45:169\u201377.","journal-title":"Am J Surg Pathol"},{"key":"1288_CR4","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1016\/j.clgc.2020.04.004","volume":"18","author":"M Vannucchi","year":"2020","unstructured":"Vannucchi M, Minervini A, Salvi M, et al. TFE3 gene rearrangement in perivascular epithelioid cell neoplasm (PEComa) of the genitourinary tract. Clin Genitourin Cancer. 2020;18:e692\u20137.","journal-title":"Clin Genitourin Cancer"},{"key":"1288_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/his.12949","volume":"69","author":"XT Wang","year":"2016","unstructured":"Wang XT, Xia QY, Ni H, et al. Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel NONO\u2013TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum. Histopathology. 2016;69:450\u20138.","journal-title":"Histopathology"},{"key":"1288_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/jclinpath-2020-206899","volume":"73","author":"K Pinto","year":"2020","unstructured":"Pinto K, Chetty R. Gene of the month: TFE3. J Clin Pathol. 2020;73:691\u20134.","journal-title":"J Clin Pathol"},{"key":"1288_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/PAS.0b013e31818fbdff","volume":"33","author":"P Argani","year":"2009","unstructured":"Argani P, Aulmann S, Karanjawala Z, et al. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol. 2009;33:609\u201319.","journal-title":"Am J Surg Pathol"},{"key":"1288_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","volume":"40","author":"P Argani","year":"2016","unstructured":"Argani P, Zhong M, Reuter VE, et al. TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers. Am J Surg Pathol. 2016;40:723\u201337.","journal-title":"Am J Surg Pathol"},{"key":"1288_CR9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/PAS.0000000000000502","volume":"39","author":"Q Rao","year":"2015","unstructured":"Rao Q, Shen Q, Xia QY, et al. PSF\/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. Am J Surg Pathol. 2015;39:1181\u201396.","journal-title":"Am J Surg Pathol"},{"key":"1288_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/path.5470","volume":"251","author":"XT Wang","year":"2020","unstructured":"Wang XT, Fang R, Zhang RS, et al. Malignant melanotic Xp11 neoplasms exhibit a clinicopathological spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification. J Pathol. 2020;251:365\u201377.","journal-title":"J Pathol"},{"issue":"suppl 1","key":"1288_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00292-019-0612-5","volume":"41","author":"K Utpatel","year":"2020","unstructured":"Utpatel K, Calvisi DF, K\u00f6hler G, et al. Complexity of PEComas: a diagnostic approach, molecular background, clinical management. Pathologe. 2020;41(suppl 1):9\u201319.","journal-title":"Pathologe"},{"issue":"5","key":"1288_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/PAS.0000000000000778","volume":"41","author":"SM McGregor","year":"2017","unstructured":"McGregor SM, Alikhan MB, John RA, et al. Melanotic PEComa of the Sinonasal Mucosa with NONO-TFE3 Fusion: an elusive Mimic of Sinonasal Melanoma. Am J Surg Pathol. 2017;41(5):717\u201322.","journal-title":"Am J Surg Pathol"},{"key":"1288_CR13","doi-asserted-by":"publisher","unstructured":"Argani P, Zhang L, Sung YS, et al. A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor. Genes Chromosomes Cancer. 2019;13:10.1002\/gcc.22801. https:\/\/doi.org\/10.1002\/gcc.22801.","DOI":"10.1002\/gcc.22801"},{"issue":"4","key":"1288_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/CCO.0000000000000649","volume":"32","author":"C Fabbroni","year":"2020","unstructured":"Fabbroni C, Sbaraglia M, Sanfilippo R. Medical treatment of advanced malignant perivascular epithelioid cell tumors. Curr Opin Oncol. 2020;32(4):301\u20136.","journal-title":"Curr Opin Oncol"},{"key":"1288_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/cjp2.187","volume":"7","author":"M Schmiester","year":"2021","unstructured":"Schmiester M, Dolnik A, Kornak U, et al. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms. J Pathol Clin Res. 2021;7:3\u20139.","journal-title":"J Pathol Clin Res"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-023-01288-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T05:06:54Z","timestamp":1673845614000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-023-01288-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1186\/s13000-023-01288-x","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data reported here were obtained in agreement with the Ethics Committee of the Ningbo Clinical\u00a0 Pathology\u00a0Diagnosis Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was waived because the submission did not include images that might identify the recipients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors state that there are no conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}